David T. Omstead

Engineering peptide-targeted liposomal nanoparticles optimized for improved selectivity for HER2-positive breast cancer cells to achieve enhanced in vivo efficacy

Baksun Kim, Jae-Ho Shin, Junmin Wu et al. · Journal of Controlled Release · 2020 · 72 citations · Full text

Nanoparticles, Nanomedicine, Engineering +10

Dual-receptor targeted strategy in nanoparticle design achieves tumor cell selectivity through cooperativity

Jared F. Stefanick, David T. Omstead, Tanyel Kiziltepe et al. · Nanoscale · 2019 · 66 citations

In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myeloma

David T. Omstead, Franklin Mejia, Jenna Sjoerdsma et al. · Journal of Hematology & Oncology · 2020 · 34 citations · Full text

Mouse pulmonary interstitial macrophages mediate the pro-tumorigenic effects of IL-9

Yongyao Fu, Abigail Pajulas, Jocelyn Wang et al. · Nature Communications · 2022 · 28 citations · Full text

Optimizing design parameters of a peptide targeted liposomal nanoparticle in an in vivo multiple myeloma disease model after initial evaluation in vitro

Jared F. Stefanick, David T. Omstead, Jonathan D. Ashley et al. · Journal of Controlled Release · 2019 · 21 citations

Nanoparticles, Nanomedicine, Engineering +8